COMPANY Data
Companies by Sector
More than 6000 listed
My FAVORITES
Movers and SHAKERS
electroCore to Present at the Canaccord Genuity Growth Conference

electroCore to Present at the Canaccord Genuity Growth Conference

 

ROCKAWAY, NJAug. 02, 2021 (GLOBE NEWSWIRE) --  electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will give a corporate presentation and be available for virtual one-on-one meetings at the  Canaccord Genuity Growth Conference. The conference is taking place virtually from  August 10 - 12, 2021. Details for the presentation are as follows:

Canaccord Genuity Growth Conference:
Date:  Thursday, August 12, 2021
Time:  8:30 am EDT
Investors can register for the conference HERE.

Following the conference a webcast replay of the presentation will be available on the Investor section of the company’s website, www.electrocore.com.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.



Investors:
Rich CockrellCG Capital
404-736-3838
ecor@cg.capital

or

Media Contact:
Jackie Dorsky
electroCore
908-313-6331
Jackie.dorsky@electrocore.com


NEWS Channel
No News
RESEARCH Reports
No News
ChannelCast VIDEOS